|
| 36398985 | Achieving a Representative Sample of Asian Americans in Biomedical Research Through Community-Based Approaches: Comparing Demographic Data in the <i>All of Us</i> Research Program With the American Community Survey. | J Transcult Nurs | 2023 |
| 37594966 | Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program. | PLoS One | 2023 |
| 37352211 | Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. | PLoS One | 2023 |
| 37214806 | Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design. | medRxiv | 2023 |
| 35294480 | Epidemiology of atrial fibrillation in the All of Us Research Program. | PLoS One | 2022 |
| 36173112 | Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence. | mSphere | 2022 |
| 36048778 | An Overview of Cancer in the First 315,000 All of Us Participants. | PLoS One | 2022 |
| 34358277 | Racial, ethnic, and gender differences in obesity and body fat distribution: An All of Us Research Program demonstration project. | PLoS One | 2021 |
| 33497675 | Predictive Analytics for Glaucoma Using Data From the All of Us Research Program. | Am J Ophthalmol | 2021 |
| 35155998 | Pediatric data from the <i>All of Us</i> research program: demonstration of pediatric obesity over time. | JAMIA Open | 2021 |
| 34941480 | Geographic Variation in Obesity at the State Level in the All of Us Research Program. | Prev Chronic Dis | 2021 |
| 32117849 | Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank. | Front Public Health | 2020 |
| 31749403 | The impact of sample processing on inflammatory markers in serum: Lessons learned. | World J Biol Psychiatry | 2020 |
| 32850593 | Mini-Review of Laboratory Operations in Biobanking: Building Biobanking Resources for Translational Research. | Front Public Health | 2020 |
| 32582289 | Impact of Diverse Data Sources on Computational Phenotyping. | Front Genet | 2020 |
| 31699749 | Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile. | BMJ Open | 2019 |
| 30498369 | Association of mitochondrial DNA copy number with self-rated health status. | Appl Clin Genet | 2018 |
| 28881617 | Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility gene. | Oncotarget | 2017 |
| 26823519 | PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. | J Natl Cancer Inst | 2016 |
| 26261251 | Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. | J Clin Oncol | 2015 |
| 26315354 | Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. | J Natl Cancer Inst | 2015 |
| 24479488 | Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer. | BMC Med Genomics | 2014 |
| 25472679 | Establishment of the cancer prevention study II nutrition cohort colorectal tissue repository. | Cancer Epidemiol Biomarkers Prev | 2014 |
| 24774302 | Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome. | BMC Med Genomics | 2014 |
| 24853948 | Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer. | Genet Epidemiol | 2014 |
| 24504028 | Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status. | Sci Rep | 2014 |
| 24728189 | The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. | Hum Mol Genet | 2014 |
| 24728075 | Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer. | Cancer Res | 2014 |
| 23571109 | Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel. | Hum Mol Genet | 2013 |
| 23913208 | Survival prediction based on inherited gene variation analysis. | Methods Mol Biol | 2013 |
| 23637064 | Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. | Cancer Epidemiol Biomarkers Prev | 2013 |
| 23535731 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. | Nat Genet | 2013 |
| 23535730 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. | Nat Genet | 2013 |
| 23535648 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. | Nat Commun | 2013 |
| 23535649 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. | Nat Commun | 2013 |
| 22282663 | Ovarian cancer risk associated with inherited inflammation-related variants. | Cancer Res | 2012 |
| 22675446 | Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. | PLoS One | 2012 |
| 21274727 | Germline PKHD1 mutations are protective against colorectal cancer. | Hum Genet | 2011 |
| 21497289 | Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. | J Mol Diagn | 2011 |
| 19245716 | Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. | BMC Cancer | 2009 |
| 19690179 | Functional and clinical significance of variants localized to 8q24 in colon cancer. | Cancer Epidemiol Biomarkers Prev | 2009 |
| 19165610 | BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter. | Clin Exp Metastasis | 2009 |
| 18628249 | Association of vitamin D receptor gene variants, adiposity and colon cancer. | Carcinogenesis | 2008 |
| 17044080 | Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history. | Prostate | 2007 |
| 17296370 | Association of testis derived transcript gene variants and prostate cancer risk. | J Urol | 2007 |
| 17507624 | Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. | Cancer Epidemiol Biomarkers Prev | 2007 |
| 16614120 | Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. | Cancer Epidemiol Biomarkers Prev | 2006 |
| 17164384 | Vitamin D receptor genotypes/haplotypes and prostate cancer risk. | Cancer Epidemiol Biomarkers Prev | 2006 |
| 16434482 | Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. | Hum Mol Genet | 2006 |
| 16569655 | Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. | Carcinogenesis | 2006 |